![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Genentech |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002250 |
To test the effectiveness of recombinant human CD4 Immunoglobulin G (CD4-IgG) in the treatment of HIV-associated immune thrombocytopenic purpura in patients with all levels of HIV infection.
Condition | Intervention | Phase |
---|---|---|
Immune Thrombocytopenic Purpura ( ITP ) HIV Infections |
Drug: CD4-IgG |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Dose Comparison |
Official Title: | A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patients must have the following:
Prior Medication:
Allowed:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions and symptoms are excluded:
Concurrent Medication:
Excluded:
Patients with the following are excluded:
Prior Medication:
Excluded for a minimum of 4 weeks prior to study entry:
Prior Treatment:
Excluded for a minimum of 4 weeks prior to study entry:
Study ID Numbers: | 076A, D0177g |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002250 |
Health Authority: | United States: Food and Drug Administration |
Recombinant Proteins IgG Drug Evaluation Antigens, CD4 |
Purpura Sexually Transmitted Diseases, Viral Hematologic Diseases Blood Platelet Disorders Blood Coagulation Disorders Acquired Immunodeficiency Syndrome Hemostatic Disorders Purpura, Thrombocytopenic Immunologic Deficiency Syndromes Virus Diseases |
Thrombocytopathy Signs and Symptoms Antibodies Thrombocytopenia HIV Infections Sexually Transmitted Diseases Immunoglobulin G CD4 Immunoadhesins Retroviridae Infections Immunoglobulins |
Skin Manifestations RNA Virus Infections Slow Virus Diseases Immunologic Factors Immune System Diseases |
Physiological Effects of Drugs Lentivirus Infections Infection Pharmacologic Actions |